Prospective analyses have yet to uncover a consistent relationship between vitamin D status and incidence and mortality of rarer cancers including esophageal and upper gastrointestinal cancers. We searched PubMed for literature about the epidemiology of upper gastrointestinal cancers and vitamin D published over the last decade and then summarized and critiqued the results of these studies in this review. The search yielded nine relevant studies. Overall, no consistent relationship was reported between serum vitamin D levels or a surrogate and upper gastrointestinal cancers. Four studies reported negative correlations between vitamin D status and upper gastrointestinal cancer, three reported positive correlations, one reported no correlation, and one reported both positive and negative correlations. No relationship has been established on the basis of epidemiologic data, but studies examining sun exposure consistently report an inverse association with esophageal cancer. The current literature is limited by the methods used to assess vitamin D status, lack of specific data for the types of upper gastrointestinal cancer, and failure to establish a temporal relationship between vitamin D status assessment and presentation of upper gastrointestinal cancer. It is possible that the lack of a consistent relationship is a consequence of inaccurate and imprecise assessment of vitamin D status. Cancer Epidemiol Biomarkers Prev; 1-8. Ó2013 AACR.
Introduction
The association between vitamin D status and cancer epidemiology is currently a heavily researched topic, and equally as heavily debated. Low serum 25-hydroxyvitamin D levels have been associated with increased risk of breast (1, 2) , colon (2, 3) , and bladder cancer (4) among others. The association of vitamin D status with cancer of the prostate (2) and skin (5) is less clear. Increasing 25-hydroxyvitamin D levels may be associated with an increased risk of prostate cancer (6, 7) and are associated with increased risk of melanoma and nonmelanoma skin cancer (5, 8, 9) . However, with respect to melanoma this may be confounded by the carcinogenic affects of UV radiation on the skin. In fact, in those with a diagnosis of malignant melanoma higher 25-hydroxyvitamin D levels have been associated with less advanced tumor stage and decreased tumor depth (10) . In addition, some have suggested that there may be a role for vitamin D in controlling the progression of cutaneous malignancies (11) , thus highlighting the equipoise that exists about cancer and vitamin D.
A suggested link between UVB radiation exposure and reduced risk of cancer has been proposed on the basis of ecologic evidence (12) , but prospective analyses have yet to uncover a consistent relationship between vitamin D status and cancer mortality in general (13) . This is especially true for rarer cancers including esophageal and upper gastrointestinal cancers for which an association has not been established (14) , although no adequate summary of the epidemiologic evidence exists. We have a particular interest in vitamin D and its importance in the esophagus and the development and treatment of esophageal adenocarcinoma (15, 16) , and set out to summarize the current literature about the epidemiology of upper gastrointestinal cancers and vitamin D status in this review.
Materials and Methods
We searched PubMed for publications listed under the MeSH terms "Vitamin D" and "Esophagus" and "Adenocarcinoma," which yielded no results. We then expanded our search to include literature addressing vitamin D and sun exposure and any esophageal malignancies or gastric carcinomas published in the past decade. Abstracts of search results were surveyed for studies that examined the epidemiology of serum 25-hydroxyvitamin D levels or surrogates thereof and any of the above-mentioned cancers. These publications were then examined in more detail for their methods, results, and conclusions, which we report in this review. This is neither a meta-analysis nor a systematic review.
Results
Overall, 9 observational studies examining the relationship between 25-hydroxyvitamin D levels (or a surrogate for 25-hydroxyvitamin D levels) and upper gastrointestinal cancer were reviewed (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) . The results are summarized in Tables 1 and 2 . One of these studies examined esophageal squamous cell dysplasia and was included because of the disease's relationship to esophageal cancer. No consistent relationship was reported between serum 25-hydroxyvitamin D levels or a surrogate and upper gastrointestinal cancers; 4 studies reported negative correlations between vitamin D status and upper gastrointestinal cancer, 3 reported positive correlations, 1 reported no correlation, and 1 reported both positive and negative correlations. The results did not seem to trend systematically with the year of publication. All 3 studies examining esophageal cancer and UV radiation exposure reported negative correlations.
The 4 studies that reported lower incidence of upper gastrointestinal cancer with higher levels of 25-hydroxyvitamin D or surrogates thereof were Tran and colleagues (18), Lipworth and colleagues (25), Giovannucci and colleagues (23) , and Boscoe and Schymura (17) . Tran and colleagues (18) assessed cumulative ambient UVB radiation exposure and its relationship to esophageal cancer. Investigators reported an 18% decrease in risk for esophageal adenocarcinoma, a 17% decrease for esophago-gastric junction adenocarcinoma, and a nonstatistically significant decrease in esophageal squamous cell carcinoma (ESCC) for each SD increase in UVB irradiance, which was 10 7 J/m 2 . Lipworth and colleagues (25) , in a case-control study in Italy, reported a 16% decrease in ESCC for each 1.14 mg/d increase in dietary vitamin D intake before diagnosis, the SD among controls. This study did not examine adenocarcinoma of the esophagus. In both studies by Tran and colleagues (18) and Lipworth and colleagues (25) , relationships were stronger when assessment of vitamin D status, by UVB irradiance or dietary vitamin D intake, was reported as a categorical variable by tertile (Table 1) . Giovannucci and colleagues (23) discovered a statistically significant inverse correlation between predicted serum 25-hydroxyvitamin D and incidence of esophageal cancer in the Health Professionals Follow-up Cohort. The cohort is composed of 51,529 males and has been followed since 1986 with information updates every 2 to 4 years. Investigators used data from this population to construct a model to predict 25-hydroxyvitamin D serum concentrations. Each 25-nmol/L increase in predicted 25-hydroxyvitamin D corresponded to a 63% decrease in esophageal cancer incidence. Finally, Boscoe and Schymura (17) reported a 27% increase in incidence and 36% increase in mortality of esophageal cancer in populations receiving an annual average of 650 kJ/m 2 -y UV exposure versus 1,540 kJ/m 2 -y, albeit in non-Hispanic White males only. A weaker relationship was reported in non-Hispanic White females. The authors report that this relationship is proportional so that populations receiving 1,100 kJ/m 2 -y could be expected to have half of the increased risk displayed by those receiving 650 kJ/m 2 -y. The authors analyzed a Black cohort separately and reported limited data because of the inconsistency of the results, but did note that the esophagus was the only cancer site that displayed a higher relative risk of cancer in the north versus south United States, in males and females, for both incidence and mortality. In this study, relative risks ranged from 1.3 to 1.5 (17) .
The 3 studies that reported higher incidence of upper gastrointestinal cancer with higher vitamin D status were Mulholland and colleagues (26), Chen and colleagues (22) , and Abnet and colleagues (19) . Most recently, Mulholland and colleagues (26) evaluated the relationship between vitamin D intake and incidence of esophageal adenocarcinoma in a case-control study using an Ireland-based population cohort, called "Factors Influencing the Barrett's Adenocarcinoma Relationship (FINBAR)." A positive association was reported between the highest and lowest tertile of vitamin D intake and esophageal adenocarcinoma with OR, 1.99; 95% confidence interval (CI), 1.03-3.86. This association did not persist for normal weight individuals, individuals negative for Helicobacter pylori, or those who never smoked, but the authors reported no interaction between these variables and vitamin D intake (26) . Pretrial 25-hydroxyvitamin D levels were correlated to subsequent development of ESCC in men in a 2007 casecontrol study by Chen and colleagues (22) . There was no significant correlation between pretrial serum 25-hydroxyvitamin D and development of gastric carcinoma, but in men pretrial 25-hydroxyvitamin D level was positively correlated with ESCC development. Abnet and colleagues (19) examined the association between serum 25-hydroxyvitamin D and esophageal squamous cell dysplasia in the same population used by Chen and colleagues (22) . They found a positive correlation between the 2 variables in both men and women with relative risk (RR), 1.86; 95% CI, 1.35-2.62. The relative risk was greater for women than in men, in contrast to the statistic reported by Chen and colleagues (22) , which found a positive correlation between vitamin D and esophageal squamous cell cancer only in men.
Abnet and colleagues (20) reported no correlation between serum 25-hydroxyvitamin D levels and upper gastrointestinal cancer, although analysis did yield some statistically significant trends in certain subgroups (20) . This nested case-control design used the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers and examined the relationship between upper gastrointestinal cancer and circulating serum 25-hydroxyvitamin D in 1,065 cases. In a subgroup analysis of 256 cases of esophageal cancer, no statistically significant trend was found over 6 levels of serum 25-hydroxyvitamin D status. The same was true when the 142 cases of squamous cell carcinoma and 104 cases of adenocarcinoma were looked at separately. Likewise, there was no statistically significant trend for any type of gastric cancer, although statistically significant ORs were calculated for certain comparisons between categories of serum 25-hydroxyvitamin D levels (20) .
Chen and colleagues (21) reported both positive and negative correlations in a study taking place in China that looked for an ecologic relationship between the geographic distribution of ambient UVB irradiance, measured in milliwatts per meter squared (mW/m 2 ), and incidence and mortality of esophageal and gastric cancer. Esophageal cancer mortality decreased by 8% and incidence by 27% for each 10 mW/m 2 increase in UVB irradiance. However, the inverse relationship between UVB irradiance and esophageal cancer mortality and incidence was restricted to rural counties. In these counties, each 10 mW/m 2 increase in UVB irradiance predicted an 11% and a 58% decrease in esophageal cancer mortality and incidence, respectively (21) . In contrast, in urban counties each 10 mW/m 2 increase in UVB irradiance predicted no change in mortality and a 12% increase in esophageal cancer incidence. In comparison, gastric cancer mortality decreased by 3% and incidence by 13% for each 10 mW/ m 2 increase in UVB irradiance. When stratified by county (urban or rural) UVB irradiance was inversely correlated with gastric cancer mortality only in urban counties, and with gastric cancer incidence only in rural counties; it was positively correlated with gastric cancer incidence in urban counties (21) .
Discussion
The most apparent limitation to the existing literature is the methods used to estimate vitamin D status. Only 3 of 9 publications used serum 25-hydroxyvitamin D as a measure, the most accurate way to estimate vitamin D status (28) . A single blood sample obtained in the spring or fall offers a reasonable estimate of the average serum 25-hydroxyvitamin D over a 1-year period (29) . However, using a single serum sample still has its limitations, possibly underestimating statistical relationships (29) . As Giovannucci and colleagues (23) pointed out, one time serum 25-hydroxyvitamin D measurements can be transiently high or low. Tran and colleagues (18) contest that they may not account for the impact of vitamin D on esophageal carcinogenesis, which may take place over a lifetime and exhibit a latency period with respect to this impact.
Furthermore, these studies pose the issue of temporality. The methods used in the published data did not allow for a calculation of the amount of time elapsed between evaluation of serum 25-hydroxyvitamin D and diagnosis of upper gastrointestinal cancer. This was exemplified in the study of Chen and colleagues (22) . After obtaining pretrial serum 25-hydroxyvitamin D levels, subjects were followed over a 5-year period, establishing a prospective timeline between the serum 25-hydroxyvitamin D measurement and development of upper gastrointestinal cancer. This is a strength of the study; however, neither follow-up serum samples nor samples at the time of cancer mortality or incidence were assayed. Only the initial serum 25-hydroyvitamin D level was used as a One point worthy of mention in the study of Abnet and colleagues (19) is the method used to identify squamous cell dysplasia. Investigators used a staining test that had a range of specificity of 40% to 95% for the detection of higher-grade dysplasia or early neoplasia, and an even lower specificity for dysplasia of lower grades. This wide range of specificity along with the fact that subjects with any grade of dysplasia were included allows for the potential of false positive results. This could exaggerate the relative risk or lead to a falsely increased relative risk if a sufficient number of subjects with 25-hydroxyvitamin D levels in the upper quartiles had misclassified esophageal disease.
Two studies used food frequency questionnaires (FFQ) to estimate a subject's vitamin D status, a method purported by one group of authors to have high reproducibility and validity (25) . Evidence suggests that surrogates such as dietary intake and vitamin supplementation are poor predictors of vitamin D status. A model using physical inactivity, skin pigmentation, dietary intake, body mass index (BMI), and region could account for only 28% of the variability in serum 25-hydroxyvitamin D levels (23) . In this model, physical inactivity and skin pigmentation were the best predictors. This is logical when one considers that approximately 80% to 90% of vitamin D may be obtained from synthesis in the skin (30) . In a study of a Sydney, Australia population, variables typically considered as surrogates of sun exposure, physical activity, and smoking, were documented as significant predictors of serum 25-hydroxyvitamin D levels (31) . Interestingly, the same study did not yield sun exposure itself as a significant predictive factor of vitamin D status.
It is likely that factors predicting vitamin D status differ according to race. In a Chicago, Illinois study, predictors of vitamin D status were different for men of European versus African descent. In European American men, the strongest predictors were season and lifetime sun exposure followed by income and BMI. In African American men, dietary and supplemental vitamin D intake were major predictors (32) . A global report on hypovitaminosis D concluded that not only skin pigmentation but also cultural differences such as certain clothing practices significantly influence vitamin D status (33) . The impact of skin color on the studies presented in this review is likely limited, however, considering most of the cohorts examined were largely non-Black. Studies that did not report on race were conducted in Irish, Italian, and Chinese populations and presumably consisted of a negligible percentage of Black subjects considering the demographics of these countries (19, 21, 22, 25, 26) . Furthermore, 2 of the studies not reporting on race used 25-hydroxyvitamin D levels obviating the need to use skin color as predictor of vitamin D status. Boscoe and Schymura (17) analyzed non-Hispanic White and Black cohorts separately to control for the impact of skin color on vitamin D status.
Predictors of vitamin D status and vitamin D status itself may also differ by gender; indeed 2 studies reviewed here reported correlations that differed between men and women (17, 22) . In a study conducted in the Netherlands, gender and season were the major predictors of vitamin D status. Men tended to have higher serum 25-hydroxyvitamin D levels than women. When parsed by gender, physical activity and season remained as correlates in men, whereas physical activity and estradiol levels were the main determinants in women (34) .
Additional evidence supports winter season, low vitamin D dietary and supplement intake, high BMI, physical inactivity, and low milk and calcium intake as major determinants of low vitamin D status (35) , highlighting the myriad of opinions about predictors of vitamin D and the complexity of using surrogate markers to predict vitamin D status. In addition, FFQs allow for the potential of recall bias. This is exemplified in the report by Mulholland and colleagues (26) in which study participants were asked to report dietary habits and BMI for a 12-month period beginning 5 years before the administration of the FFQ. This should be considered when interpreting these results.
Three studies examined the correlation of UV exposure to incidence and mortality of esophageal cancer. Interestingly, all 3 studies reported inverse correlation between UV exposure, a proposed surrogate for vitamin D status, and esophageal cancer. However, this method imposes some limitations. Measurements of ambient UVB irradiance may not reliably approximate serum 25-hydroxyvitamin D levels or even UVB exposure. In addition, Chen and colleagues (21) did little to control for significant confounding variables, including smoking, alcohol intake, and BMI. But, these investigators reported both positive and negative correlations between UVB exposure and upper gastrointestinal cancer. Esophageal cancer mortality and incidence was inversely correlated to UVB irradiance only in rural counties, a restriction that could reflect the increased amount of UVB exposure that the agrarian worker presumably gets. This would strengthen the inference that higher vitamin D status may help limit esophageal cancer mortality and incidence, as the authors point out. However, it could also reflect other lifestyle factors associated with the agrarian lifestyle that could protect against esophageal cancer mortality and incidence, confounding its relationship to UVB exposure.
The inconsistency of the relationship should be reiterated: UVB irradiance was inversely correlated with esophageal and gastric cancer incidence in rural counties, but positively correlated in urban counties, and an inverse correlation to gastric cancer mortality was only present in urban counties. These differences could be a consequence of different neoplastic process between esophageal and gastric cancer; or statistically significant relationships could have been found serendipitously because of the increased probability of making a type I error when conducting numerous tests for significance. Nevertheless, there may be merit to using UVB irradiance as a surrogate for vitamin D status. Even at high latitudes, season influenced vitamin D more than diet, ethnicity, and vitamin intake suggesting that sun exposure is the major determinant of vitamin D status (36) .
The study by Tran and colleagues (18) was also limited by the possibility that UVB irradiance does not accurately predict vitamin D status. However, investigators were able to more accurately estimate UVB exposure by approximating individual lifetime exposure to UVB and collecting data on many confounding variables. In addition, they examined UVB exposure at different age periods for each subject in an attempt to evaluate the contribution of estimated vitamin D status to the prevention of esophageal cancer over one's lifetime. This is a strength afforded by this study design and a limitation of study designs that assess serum 25-hydroxyvitamin D status at one particular instance, thus failing to account for the possibility of a latent period for esophageal carcinogenesis.
Two studies published in the last decade, a meta-analysis and a systematic review, examined the risk of subsequent cancer after diagnosis of skin cancer, essentially using prior skin cancer as a surrogate for UV irradiance. After previous diagnosis of squamous cell carcinoma, basal cell carcinoma, or nonmelanoma skin cancer, Grant (24) reported relative risks for developing gastric cancer and esophageal cancer of 0.67 and 0.60, respectively. Wheless and colleagues (27) reported no association between previous diagnosis of skin cancer and subsequent esophageal cancer. This review included the data published in the study by Grant (24) .
The discrepancy in the results of the investigators may be explained by the suggestion that the absence of a skin cancer diagnosis does not preclude adequate exposure to UVB light. If this is the case-that subjects with adequate UVB exposure are significantly represented in the group without a skin cancer diagnosis--then the inverse correlation reported by Grant (24) would attenuate. Nevertheless, if in fact sun exposure is linked to high vitamin D status, the findings by Grant (24) support the hypothesis that vitamin D plays a role in the prevention of cancer. In addition, Grant (24) astutely excluded melanocytic skin cancers, which are associated with intermittent and blistering sun exposure at an early age (37) and the presence of melanocytic nevi (38) , the factors that may correlate less closely with overall sun exposure.
Despite a particular interest in adenocarcinoma of the esophagus, we decided to include all upper gastrointestinal cancers in this review because of the limited information on the topic. However, it has been suggested that adenocarcinoma of the esophagus and gastric cardia share many similar risk factors that they may be considered together, and may even be of the same etiology (39) . Other sources suggest otherwise (40) , and this could be one of the limitations of this review.
The mechanism by which vitamin D may impact carcinogenesis in the upper gastrointestinal tract, in particular adenocarcinoma of the esophagus, is uncertain, but may involve the immunomodulatory role of vitamin D in the regulation of immune cells involved in reflux-related esophageal disease including CD4 þ T cells (41) (42) (43) (44) (45) (46) , macrophages (43, 47, 48) , and dendritic cells (49) (50) (51) (52) , and key signaling pathways including Wnt (53, 54) , Hedgehog (55-57), NF-kB (58) , and IL-6-JAK-STAT (59, 60) . The discrepancy between the role of vitamin D in cancers of lower gastrointestinal tract, including colorectal cancer where there is strong evidence of a protective effect (61, 62) , and upper gastrointestinal cancers, including esophageal adenocarcinoma where the relationship is still unclear, may be explained by different pathogeneses of these 2 diseases. Esophageal adenocarcinoma is thought to arise from a metaplasia-neoplasia sequence as a consequence of chronic inflammation induced by bile and acid reflux (63) , whereas it is generally accepted that colorectal cancer progresses through an adenoma-carcinoma sequence (64) . The role of inflammation in these 2 disease states is also likely different and could impact the response to vitamin D status.
In summary, the current literature is limited in many cases by the method used to assess vitamin D status, lack of specific data for the types of upper gastrointestinal cancer including subtypes of esophageal cancer, and failure to establish a temporal relationship between vitamin D status assessment and presentation of upper gastrointestinal cancer. The most weight should be placed on the 3 studies using serum 25-hydroxyvitamin D to assess vitamin D status as this limits confounding and misclassification. However, still there was no consensus relationship among these 3 datasets. Furthermore, there is merit to ecologic studies and studies examining UV exposure that attempt to estimate an individual's vitamin D status over a lifetime. This may better predict the impact of vitamin D status on esophageal cancer if long-term vitamin D status is more relevant to carcinogenesis than current or recent vitamin D status. Future studies should aim to combine individual data about lifetime sun exposure, surrogate markers for vitamin D status, and serum 25-hydroxyvitamin D levels, ideally at multiple intervals throughout the study period.
It is possible that the lack of a consistent relationship reported across the 9 studies reviewed is a consequence of study design. Inaccurate and imprecise assessment of vitamin D status could certainly attenuate, exaggerate, or obscure relationships, but this would require methods that systematically under assessed or over assessed vitamin D status. It is likely that studies using measurements other than serum 25-hydroxyvitamin D to assess vitamin D status are both inaccurate and imprecise. In addition, each different subtype of upper gastrointestinal cancer-including esophageal adenocarcinoma and squamous cell carcinoma, which have distinctly different pathologies-may exhibit a different relationship with vitamin D levels and should be assessed separately. In conclusion, no consistent relationship between vitamin D status and upper gastrointestinal cancers is currently evident, but studies using sun exposure as a main measurement consistently report lower rates of esophageal cancer with higher levels of UV irradiance.
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